STOCK TITAN

Vanguard Portfolio Management (VCYT) reports 4.51M shares, 5.67% stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Veracyte Inc reported beneficial ownership by Vanguard Portfolio Management LLC. Vanguard Portfolio Management beneficially owns 4,512,852 shares of Veracyte common stock, representing 5.67% of the class. The filing shows 68,122 shares with sole voting power and 4,512,852 shares with sole dispositive power. The filing is signed by Ashley Grim on 04/29/2026.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 4,512,852 shares Item 4(a) beneficial ownership
Percent of class 5.67% Item 4(b) percent of class
Sole voting power 68,122 shares Item 4(c)(i) sole power to vote
Sole dispositive power 4,512,852 shares Item 4(c)(iii) sole power to dispose
Signature date 04/29/2026 Signed by Ashley Grim
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: Veracyte Inc"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 4512852"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole dispositive power regulatory
"(iii) Sole power to dispose or to direct the disposition of: 4512852"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.





92337F107

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Portfolio Management LLC and the following affiliates of Vanguard Portfolio Management LLC or business divisions of such affiliates: Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Portfolio Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Portfolio Management LLC, or business divisions of such subsidiaries whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.


SCHEDULE 13G



Vanguard Portfolio Management
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:04/29/2026

FAQ

How many Veracyte (VCYT) shares does Vanguard Portfolio Management report owning?

Vanguard Portfolio Management reports 4,512,852 shares of Veracyte common stock. This figure is reported in Item 4(a) as the amount beneficially owned in the Schedule 13G excerpt.

What percentage of Veracyte does Vanguard Portfolio Management own according to the filing?

The filing states Vanguard holds 5.67% of Veracyte's common stock. This percentage is given in Item 4(b) alongside the reported share count of 4,512,852.

What voting and dispositive powers does Vanguard report for VCYT shares?

Vanguard reports 68,122 shares as sole voting power and 4,512,852 shares as sole dispositive power. Shared voting and dispositive powers are reported as 0 in this excerpt.

Who signed the Schedule 13G filing for Vanguard and when was it signed?

The filing is signed by Ashley Grim, Head of Global Fund Administration. The signature date recorded on the excerpt is 04/29/2026.

Does the filing indicate Vanguard acts on behalf of other entities for these Veracyte shares?

Yes. The filing explains that Vanguard Portfolio Management exercises dispositive power over securities held by Vanguard affiliates and funds, including Vanguard Fiduciary Trust Company and Vanguard Global Advisers, LLC.